EP
TYRA icon

Eversept Partners’s Tyra Biosciences TYRA Stock Holding History

Eversept Partners’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.04M Sell
27,055
-251,509
-90% -$8.14M 0.05% 107
2025
Q4 		$7.32M Buy
278,564
+5,858
+2% +$108K 0.37% 64
2025
Q3 		$3.82M Buy
+272,706
New +$3.11M 0.26% 55

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Eversept Partners's TYRA Position: Q1 2026 in Review

Eversept Partners reduced its Tyra Biosciences (TYRA) stake by 90% in Q1 2026, selling an estimated $8.14M and leaving 27,055 shares worth $1.04M. The position accounts for 0.05% of the portfolio, ranked #107.

Eversept Partners first reported a position in TYRA in Q3 2025 and has held it in 3 quarters since. The position peaked at $7.32M in Q4 2025. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Eversept Partners held 27,055 shares of Tyra Biosciences worth $1.04M as of Q1 2026.
  • Eversept Partners sold 251,509 Tyra Biosciences shares in Q1 2026, an estimated $8.14M.
  • Tyra Biosciences made up 0.05% of Eversept Partners's portfolio in Q1 2026, its #107 holding.
  • Eversept Partners first reported a position in Tyra Biosciences in Q3 2025 and has held it in 3 quarters since.
  • Eversept Partners's Tyra Biosciences position peaked at $7.32M in Q4 2025.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Eversept Partners's 13F filing for Q1 2026, filed 15 May 2026.